Price Controls Pelosi’s Healthcare Nightmare Is Coming Back Elizabeth Wright April 24, 2021 Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research Elizabeth Wright November 20, 2020 Most Favored Nation Policy: Unfavorable to U.S. Pharmaceutical Research Elizabeth Wright September 19, 2020 Presidential Executive Orders Will Not Lower Drug Costs Elizabeth Wright July 29, 2020 Wasteful Spending on 340B Keeps Growing and Growing Elizabeth Wright June 26, 2020 Union Opposes Rate-Setting to Solve Surprise Medical Billing Elizabeth Wright April 24, 2020 « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Next » CONGRESSIONAL PIG BOOK PRIME CUTS ISSUE BRIEFS GENERAL WASTE AGRICULTURE REFORM POSTAL SERVICE TAXES TRANSPORTATION DEFENSE AVIATION & SPACE F-35 JOINT STRIKE FIGHTER PROCUREMENT HEALTH AND SCIENCE PRICE CONTROLS GOVERNMENT RUN HEALTHCARE 340B DRUG DISCOUNT PROGRAM PHARMACY BENEFIT MANAGERS TOBACCO HARM REDUCTION INNOVATION & TECHNOLOGY POLICY CENTER ANTITRUST ARTIFICIAL INTELLIGENCE BIOPHARMACEUTICALS INTELLECTUAL PROPERTY PRIVACY TECHNOLOGY AND INNOVATION TELECOMMUNICATIONS STATE ISSUES CONGRESSIONAL PIG BOOK PRIME CUTS ISSUE BRIEFS GENERAL WASTE AGRICULTURE REFORM POSTAL SERVICE TAXES TRANSPORTATION DEFENSE AVIATION & SPACE F-35 JOINT STRIKE FIGHTER PROCUREMENT HEALTH AND SCIENCE PRICE CONTROLS GOVERNMENT RUN HEALTHCARE 340B DRUG DISCOUNT PROGRAM PHARMACY BENEFIT MANAGERS TOBACCO HARM REDUCTION INNOVATION & TECHNOLOGY POLICY CENTER ANTITRUST ARTIFICIAL INTELLIGENCE BIOPHARMACEUTICALS INTELLECTUAL PROPERTY PRIVACY TECHNOLOGY AND INNOVATION TELECOMMUNICATIONS STATE ISSUES Email
Most Favored Nation Policy Is Unfavorable to U.S. Biopharmaceutical Research Elizabeth Wright November 20, 2020
Most Favored Nation Policy: Unfavorable to U.S. Pharmaceutical Research Elizabeth Wright September 19, 2020
